These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 10498386)

  • 1. Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'Etude.
    Mazoyer E; Drouet L; Soria C; Fruchard JC; Pellerin A; Arcan JC; Tobelem G
    Thromb Res; 1999 Aug; 95(4):163-76. PubMed ID: 10498386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of lipoprotein(a) with atherothrombotic events and fibrinolytic variables. A case-control study.
    Franceschini G; Cofrancesco E; Safa O; Boschetti C; Tremoli E; Mussoni L; Sirtori CR; Cortellaro M
    Thromb Res; 1995 May; 78(3):227-38. PubMed ID: 7631303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction.
    Bohula EA; Bonaca MP; Braunwald E; Aylward PE; Corbalan R; De Ferrari GM; He P; Lewis BS; Merlini PA; Murphy SA; Sabatine MS; Scirica BM; Morrow DA
    Circulation; 2016 Jul; 134(4):304-13. PubMed ID: 27440003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical factors predicting the appearance of vascular events following a transient ischemic attack].
    Purroy García F; Montaner J; Delgado P; Ribó M; Arenillas Lara JF; Quintana M; Alvarez Sabín J
    Rev Neurol; 2004 Mar 1-15; 38(5):416-21. PubMed ID: 15029517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.
    Ducrocq G; Bhatt DL; Labreuche J; Corbalan R; Porath A; Gao R; Panchenko E; Liau CS; Ikeda Y; Goto S; Amarenco P; Steg PG
    Eur J Prev Cardiol; 2014 Dec; 21(12):1509-16. PubMed ID: 23965467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive impact of daily physical activity on new vascular events in patients with mild ischemic stroke.
    Kono Y; Kawajiri H; Kamisaka K; Kamiya K; Akao K; Asai C; Inuzuka K; Yamada S
    Int J Stroke; 2015 Feb; 10(2):219-23. PubMed ID: 25381835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
    Cortellaro M; Boschetti C; Cofrancesco E; Zanussi C; Catalano M; de Gaetano G; Gabrielli L; Lombardi B; Specchia G; Tavazzi L
    Atherosclerosis; 1991 Oct; 90(2-3):109-18. PubMed ID: 1759983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting.
    Ferrières J; Cambou JP; Gayet JL; Herrmann MA; Leizorovicz A
    Int J Cardiol; 2006 Oct; 112(3):302-7. PubMed ID: 16325285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study.
    Violi F; Criqui M; Longoni A; Castiglioni C
    Atherosclerosis; 1996 Feb; 120(1-2):25-35. PubMed ID: 8645368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between site of initial symptoms and subsequent progression of disease in a prospective study of atherosclerosis progression in patients receiving long-term treatment for symptomatic peripheral arterial disease.
    Nicoloff AD; Taylor LM; Sexton GJ; Schuff RA; Edwards JM; Yeager RA; Landry GJ; Moneta GL; Porter JM;
    J Vasc Surg; 2002 Jan; 35(1):38-46; discussion 46-7. PubMed ID: 11802131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PACIFIC (Prevention of AtherothrombotiC Incidents Following Ischemic Coronary attack) Registry: Rationale and design of a 2-year study in patients initially hospitalised with acute coronary syndrome in Japan.
    Miyauchi K; Morino Y; Tsukahara K; Origasa H; Daida H;
    Cardiovasc Drugs Ther; 2010 Feb; 24(1):77-83. PubMed ID: 20352313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial.
    Blomster JI; Woodward M; Zoungas S; Hillis GS; Harrap S; Neal B; Poulter N; Mancia G; Chalmers J; Huxley R
    BMJ Open; 2016 Jan; 6(1):e009668. PubMed ID: 26747037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data.
    Diener HC; Bogousslavsky J; Brass LM; Cimminiello C; Csiba L; Kaste M; Leys D; Matias-Guiu J; Rupprecht HJ
    Cerebrovasc Dis; 2004; 17(2-3):253-61. PubMed ID: 14981346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke risk management: changes in mainstream practice.
    Kalra L; Perez I; Melbourn A
    Stroke; 1998 Jan; 29(1):53-7. PubMed ID: 9445328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cacoub PP; Abola MT; Baumgartner I; Bhatt DL; Creager MA; Liau CS; Goto S; Röther J; Steg PG; Hirsch AT;
    Atherosclerosis; 2009 Jun; 204(2):e86-92. PubMed ID: 19054514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher carotid intima media thickness predicts extracranial vascular events and not stroke recurrence among transient ischemic attack patients.
    Purroy F; Montserrat J; Begué R; Gil MI; Quílez A; Sanahuja J; Brieva L; Pardina M; Piñol-Ripoll G
    Int J Stroke; 2012 Feb; 7(2):125-32. PubMed ID: 22264364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
    Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
    Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain.
    Heinrich J; Schulte H; Schönfeld R; Köhler E; Assmann G
    Thromb Haemost; 1995 Mar; 73(3):374-9. PubMed ID: 7667818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding increases the risk of ischemic events in patients with peripheral arterial disease.
    van Hattum ES; Algra A; Lawson JA; Eikelboom BC; Moll FL; Tangelder MJ
    Circulation; 2009 Oct; 120(16):1569-76. PubMed ID: 19805650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.